| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,073 |
6,788 |
$219K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
181 |
141 |
$50K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,185 |
990 |
$23K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
268 |
246 |
$23K |
| 20610 |
|
253 |
185 |
$5K |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
98 |
74 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
12 |
$507.59 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
24 |
23 |
$497.51 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
170 |
155 |
$261.62 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
39 |
24 |
$65.61 |
| 96401 |
|
327 |
131 |
$48.62 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
275 |
246 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
652 |
559 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
215 |
204 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
651 |
561 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
31 |
25 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
54 |
48 |
$0.00 |
| 4004F |
|
13 |
13 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
54 |
48 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
13 |
13 |
$0.00 |
| 1123F |
|
37 |
30 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
29 |
26 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
55 |
53 |
$0.00 |
| 1036F |
|
67 |
65 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
66 |
59 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
13 |
13 |
$0.00 |